These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10391867)

  • 1. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine.
    Martinez JE; Romero-Steiner S; Pilishvili T; Barnard S; Schinsky J; Goldblatt D; Carlone GM
    Clin Diagn Lab Immunol; 1999 Jul; 6(4):581-6. PubMed ID: 10391867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.
    Romero-Steiner S; Libutti D; Pais LB; Dykes J; Anderson P; Whitin JC; Keyserling HL; Carlone GM
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):415-22. PubMed ID: 9220157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine.
    Bogaert D; Sluijter M; De Groot R; Hermans PW
    Vaccine; 2004 Sep; 22(29-30):4014-20. PubMed ID: 15364451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
    Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
    J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine.
    Zielen S; Bühring I; Strnad N; Reichenbach J; Hofmann D
    Infect Immun; 2000 Mar; 68(3):1435-40. PubMed ID: 10678957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.
    Martinez JE; Clutterbuck EA; Li H; Romero-Steiner S; Carlone GM
    Clin Vaccine Immunol; 2006 Apr; 13(4):459-66. PubMed ID: 16603613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
    Jansen WT; Gootjes J; Zelle M; Madore DV; Verhoef J; Snippe H; Verheul AF
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):703-10. PubMed ID: 9729539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional immune responses to twelve serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults.
    Ahn JG; Kim HW; Choi HJ; Lee JH; Kim KH
    Vaccine; 2015 Sep; 33(38):4770-5. PubMed ID: 26277073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic.
    Yu X; Sun Y; Frasch C; Concepcion N; Nahm MH
    Clin Diagn Lab Immunol; 1999 Jul; 6(4):519-24. PubMed ID: 10391854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age on the response to the pneumococcal polysaccharide vaccine.
    Lee H; Nahm MH; Kim KH
    BMC Infect Dis; 2010 Mar; 10():60. PubMed ID: 20219110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls.
    McMahon BJ; Parkinson AJ; Bulkow L; Davidson M; Wainwright K; Wolfe P; Schiffman GS
    Am J Med; 1993 Dec; 95(6):589-94. PubMed ID: 8259775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
    Sigurdardottir ST; Center KJ; Davidsdottir K; Arason VA; Hjalmarsson B; Elisdottir R; Ingolfsdottir G; Northington R; Scott DA; Jonsdottir I
    Vaccine; 2014 Jan; 32(3):417-24. PubMed ID: 24300594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
    Nahm MH; Olander JV; Magyarlaki M
    J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
    Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
    J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies.
    Burton RL; Nahm MH
    Clin Vaccine Immunol; 2006 Sep; 13(9):1004-9. PubMed ID: 16960111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
    Kim KH; Seoh JY
    J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.
    Romero-Steiner S; Frasch C; Concepcion N; Goldblatt D; Käyhty H; Väkeväinen M; Laferriere C; Wauters D; Nahm MH; Schinsky MF; Plikaytis BD; Carlone GM
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1019-24. PubMed ID: 14607861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
    Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
    J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.